条件性敲除转基因小鼠Alk1基因构建脑动静脉畸形新实验模型
研究通过Tagln-Cre在Alk1-floxed小鼠中条件性敲除Alk1基因构建脑动静脉畸形(AVM)模型,55只突变小鼠中23只(42%)无血管病变、10只(18%)动静脉瘘、22只(40%)有畸形团AVM;AVM具有早期畸形团显影、血管团和引流静脉扩张及快速分流等血管造影特征,并可见微出血,系列MRI和MRA显示畸形团AVM稳定。
要点
- 55只Tagln-Cre+;Alk12f/2f突变小鼠中40%出现畸形团AVM,18%为动静脉瘘,42%无血管病变。
- 50%的AVM在MRI或MRA上可见微出血,组织学见铁沉积和巨噬细胞浸润。
- 畸形团AVM在系列MRI和MRA上稳定(初次成像平均2.9月龄,末次9.5月龄)。
核心结论
- 约40%的转基因小鼠通过复制畸形团解剖、动静脉血流动力学和微出血行为,满足稳定实验性AVM模型的要求。
- 有动静脉瘘的转基因小鼠具有可识别的遗传性出血性毛细血管扩张症表型,但较不适合用于实验建模。
- AVM发病机制可理解为胚胎期条件性Alk1基因缺失与发育中和新生小鼠中过度活跃的血管生成相结合,这对应大多数患者的先天性起源,而在生命后期遗传和血管生成事件汇合的患者中为获得性情况。
- 本研究为未来AVM病理生理学、生长、破裂和治疗性消退研究提供了一种新的实验性脑AVM模型。
研究设计与样本
- 将Alk1-floxed小鼠与删除鼠杂交,产生通过Tagln-Cre删除Alk1基因两个拷贝以形成脑AVM的子代。
- 使用MRI、MRA和DSA对AVM进行表征。
- 通过乳胶染料灌注、免疫荧光和普鲁士蓝染色对脑AVM进行组织病理学表征。
主要发现
- 55只Tagln-Cre+;Alk12f/2f突变小鼠的脑被分为三组:无可检测血管病变(第1组;55只中23只,42%)、无畸形团的动静脉瘘(第2组;55只中10只,18%)和畸形团AVM(第3组;55只中22只,40%)。
- 在11个AVM(50%)中,MRI或MRA观察到微出血。
- AVM具有早期畸形团显影、动脉和扩张引流静脉缠结以及血流快速分流的血管造影特征。
- 乳胶染料灌注证实所有AVM和动静脉瘘中均存在动静脉分流。
- 在动静脉瘘和AVM邻近区域检测到微出血,通过铁沉积、普鲁士蓝染色和CD68免疫染色显示的巨噬细胞浸润进行可视化。
局限性
- 约40%的转基因小鼠满足稳定实验性AVM模型的要求。
- 有动静脉瘘的转基因小鼠具有可识别的遗传性出血性毛细血管扩张症表型,但较不适合用于实验建模。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hereditary hemorrhagic telangiectasia is the only condition associated with multiple inherited brain arteriovenous malformations (AVMs). Therefore, a mouse model was developed with a genetics-based approach that conditionally deleted the causative activin receptor-like kinase 1 (Acvrl1 or Alk1) gene. Radiographic and histopathological findings were correlated, and AVM stability and hemorrhagic behavior over time were examined. METHODS: Alk1-floxed mice were crossed with deleter mice to generate offspring in which both copies of the Alk1 gene were deleted by Tagln-Cre to form brain AVMs in the mice. AVMs were characterized using MRI, MRA, and DSA. Brain AVMs were characterized histopathologically with latex dye perfusion, immunofluorescence, and Prussian blue staining. RESULTS: Brains of 55 Tagln-Cre+;Alk12f/2f mutant mice were categorized into three groups: no detectable vascular lesions (group 1; 23 of 55, 42%), arteriovenous fistulas (AVFs) with no nidus (group 2; 10 of 55, 18%), and nidal AVMs (group 3; 22 of 55, 40%). Microhemorrhage was observed on MRI or MRA in 11 AVMs (50%). AVMs had the angiographic hallmarks of early nidus opacification, a tangle of arteries and dilated draining veins, and rapid shunting of blood flow. Latex dye perfusion confirmed arteriovenous shunting in all AVMs and AVFs. Microhemorrhages were detected adjacent to AVFs and AVMs, visualized by iron deposition, Prussian blue staining, and macrophage infiltration using CD68 immunostaining. Brain AVMs were stable on serial MRI and MRA in group 3 mice (mean age at initial imaging 2.9 months; mean age at last imaging 9.5 months). CONCLUSIONS: Approximately 40% of transgenic mice satisfied the requirements of a stable experimental AVM model by replicating nidal anatomy, arteriovenous hemodynamics, and microhemorrhagic behavior. Transgenic mice with AVFs had a recognizable phenotype of hereditary hemorrhagic telangiectasia but were less suitable for experimental modeling. AVM pathogenesis can be understood as the combination of conditional Alk1 gene deletion during embryogenesis and angiogenesis that is hyperactive in developing and newborn mice, which translates to a congenital origin in most patients but an acquired condition in patients with a confluence of genetic and angiogenic events later in life. This study offers a novel experimental brain AVM model for future studies of AVM pathophysiology, growth, rupture, and therapeutic regression.
引用
- Han C, Lang MJ, Nguyen CL, et al. Novel experimental model of brain arteriovenous malformations using conditional Alk1 gene deletion in transgenic mice. J Neurosurg. 2021. PMID: 34740197. doi:10.3171/2021.6.JNS21717
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。